nicotine replacement combined with a novel compound (proban) for smoking cessation: a pilot study
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

nicotine replacement combined with a novel compound (proban) for smoking cessation: a pilot study

;Richard Leigh;Norman M Viner;Gerard Cox;Jeffrey W Balon;Douglas MC Wilson;Denise O’Shaughnessy;Corinne Walker;Gerry Brosky;Malcolm R Sears
religions 2001 Vol. 8 pp. 21-26
124
leigh2001canadiannicotine

Abstract

BACKGROUND: Smoking cessation rates with available pharmacological therapies remain suboptimal. Anecdotal observations with a combination of sublingual pralidoxime and ipratropium (ProBAN) suggested that these agents in combination with nicotine gum improved quit rates.

Keywords

diseases of the respiratory system

Access

DOI:
10.1155/2001/947097
URL:
http://dx.doi.org/10.1155/2001/947097

Citation

ID: 215404
Ref Key: leigh2001canadiannicotine
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
215404
Unique Identifier:
10.1155/2001/947097
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store